HIGHLIGHTS
- who: Clinicopathological Significance and collaborators from the Institute of Pathology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China have published the research: INSM1 Expression in Mesenchymal Tumors and Its Clinicopathological Significance, in the Journal: BioMed Research International of 26/06/2022
- what: The authors focus on liposarcoma, rhabdomyosarcoma, and bone tumor.
- how: The combination of GEO data and immunohistochemistry data indicated that the expression level of INSM1 was higher in AITL compared with normal control suggesting that INSM1 may be involved in pathogenesis of AITL. The results of INSM1 in public . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.